Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H27N3O4 |
Molecular Weight | 469.5317 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1N([C@H]2CCC(=O)NC2=O)C3=CC=C(CC4=CC=C(CN5CCOCC5)C=C4)C6=C3C1=CC=C6
InChI
InChIKey=MUKCJOOKCZSQNW-DEOSSOPVSA-N
InChI=1S/C28H27N3O4/c32-25-11-10-24(27(33)29-25)31-23-9-8-20(21-2-1-3-22(26(21)23)28(31)34)16-18-4-6-19(7-5-18)17-30-12-14-35-15-13-30/h1-9,24H,10-17H2,(H,29,32,33)/t24-/m0/s1
Molecular Formula | C28H27N3O4 |
Molecular Weight | 469.5317 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:15:58 GMT 2023
by
admin
on
Sat Dec 16 17:15:58 GMT 2023
|
Record UNII |
D86MF5H9WJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
831921
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000040689
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
PRIMARY | |||
|
C179502
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
PRIMARY | |||
|
2504235-67-8
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
PRIMARY | |||
|
12505
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
PRIMARY | |||
|
D86MF5H9WJ
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
PRIMARY | |||
|
155207651
Created by
admin on Sat Dec 16 17:15:59 GMT 2023 , Edited by admin on Sat Dec 16 17:15:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->DEGRADER |
IN-VITRO
|
||
|
TARGET->DEGRADER |
IN-VITRO
|
||
|
TARGET->LIGAND |
IN-VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
The high CRBN binding affinity of CFT7455 enables rapid, deep and durable degradation of IKZF1 and IKZF3 resulting in potent growth inhibitory activity in multiple myeloma cell lines and multiple types of non-Hodgkin’s lymphoma cell lines in vitro
|